-Financial results to be released on Tuesday, April 30th, 2013-
TORONTO, April 24, 2013 /CNW/ - Prism Medical Ltd. (TSXV: PM) will release its fiscal 2013 first quarter financial results on: Tuesday April 30th 2013. The Company will subsequently hold a conference call on Wednesday May 1, at 9:00 am Eastern Time to discuss the results. The call will be hosted by Mr. Stuart Meldrum, Chief Executive Officer, and Mr. George Chiarucci, Chief Financial Officer. A question and answer period will follow the corporate update.
CONFERENCE CALL DETAILS:
|DATE:||Wednesday, May 1st, 2013|
|TIME:||9:00 a.m. Eastern Time|
|DIAL-IN NUMBER:||(647) 427-7450 or (888) 231-8191|
|TAPED REPLAY:||(416) 849-0833 or (855) 859-2056|
A link to the live audio webcast of the conference call will be available on the Company's website at www.prismmedicalltd.com as well as at www.newswire.ca. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to hear the webcast.
About Prism Medical Ltd.
Prism Medical Ltd. is one of the largest providers and manufacturers of durable medical equipment and related services to the mobility challenged in Canada, the U.S. and the U.K., with more than 100,000 installations and 200,000 product solutions sold. The Prism Medical brands include Waverley Glen and ErgoSafe, North America's leading supplier of lifting, handling and repositioning aid products and services across Canada and the U.S. Freeway and Prism Service & Repair are leading suppliers of moving and handling products and services in the U.K. For further information visit: www.prismmedicalltd.com.
This document contains forward-looking statements relating to our operations and to the environment in which we operate and our strategy, action plans and investments, which may involve estimates, forecasts and projections. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict and/or are beyond our control. A number of important factors could cause actual outcomes and results to differ materially from those expressed in these forward-looking statements. These factors include those set forth in this report and our other public filings. Consequently, readers should not place any undue reliance on such forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Prism Medical Ltd.
For further information:
Chief Financial Officer
416-260-2145 ext. 229